Molecular Staging of Cancer

1 Reviews.- The Urokinase Receptor (uPAR, CD87) as a Target for Tumor Therapy: uPA-Silica Particles (SP-uPA) as a New Tool for Assessing Synthetic Peptides to Interfere with uPA/uPA-Receptor Interaction.- Molecular Regulation of Urokinase-Receptor Gene Expression as One Potential Concept for Molecular Staging and Therapy.- Stromal Cell Involvement in Cancer.- Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells In Vitro and In Vivo.- Molecular Mechanisms of Carcinogenesis in Gastric Cancer.- Clinical Implications of Molecular Diagnosis in Hereditary Nonpolyposis Colorectal Cancer.- Minimal Residual Disease in Gastric Cancer.- Minimal Residual Disease in Breast Cancer and Gynecological Malignancies: Phenotype and Clinical Relevance.- Advanced Statistical Methods for the Definition of New Staging Models.- Clinical Implications of the EGF Receptor/Ligand System for Tumor Progression and Survival in Gastrointestinal Carcinomas: Evidence for New Therapeutic Options.- 2 Original Papers.- Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer.- Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients.- Detection of Circulating Tumor Cells in Blood Using an Optimized Density Gradient Centrifugation.- Antitumoral and Antimetastatic Effects of Continuous Particle-Mediated Cytokine Gene Therapy.- Genetic Subtyping of Renal Cell Carcinoma by Comparative Genomic Hybridization.- Telomere Length and hTERT Expression in Patients with Colorectal Carcinoma.- Estimation of Concentration of Chosen Adhesive Factors in Suprarenal Tumours of "Incidentaloma"Type.- Evaluation of the Levels of bFGF, VEGF, sICAM-1, and sVCAM-1 in Serum of Patients with Thyroid Cancer.- Molecular Whole-Body Cancer Staging Using Positron Emission Tomography: Consequences for Therapeutic Management and Metabolic Radiation Treatment Planning.- Recurrences of Thyroid Cancer After Radical Surgery and Complementary Treatment: Are Macroscopic, Microscopic, Scintigraphic, and Biochemical Criteria Sufficient in the Evaluation of Radicality of Primary Treatment?.- 3 Summary.- Summary and Congress Report: Molecular Staging of Cancer - Concepts of Today, Therapies of Tomorrow.